Efficacy Multicentre Trial of ImmunoTherapy Vaccination With Abagovomab to Treat Ovarian Cancer Patients
Clinical trial NCT00418574 · TERMINATED
Trial details
- NCT number
- NCT00418574
- Sponsor
- Menarini Group
- Status
- TERMINATED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2006-12-01
- Primary completion
- 2010-12-01
- Enrollment
- 888
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.